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ObiddilQ. ‘Ihis study sought to establish the chemosensitivity 
cd patkats witb chroak hea failure. 
i%ukgmd. The veatibtory response to exetise is often 
bmased in patknts with chmnk beart failure, as chamcterized 
by the steeper regression slope relating minute ventilation to 
cahu dioxide o&put. We hypothrsized that the sensitivity of 
cbem~ors may bc reset and nay in part mediate the exercise 
hypepna sew in this coadition. 
Me&& Hypoxk and peripheral bypercspllk cbemosensitivity 
WYe studied in 38 patients with chroak heart failure (35 me& 3 
rromcn; mesa [*SE] age Y3 * 1.3 years: radionuclide left 
vwtrkulnr ejection fmctioa 25.7 f 23%) and 15 healthy control 
wbjects (II pep, 4 s mean age 54.9 f 3.0 yean) using 
bansiat iohalatbos of pare nitrogen and sin& breaths of 13% 
carboa dkuide, respe&ely. Tbe change io mitivity dur- 
iag alld exercise (2!5 W) was assessed in the first 15 patients and 
all coNml snbjects. Central bypempak cbemosensitivity was 
also .dactwlzed in 25 patients and IO coontml subjects by the 
rehsmablug of 7% carbon dioxide in 93% oxygen. Cardiof~lmo- 
nary exe&se ttsting was performed in all subjects. 
Patients with chronic heart failure are often limited % exer- 
tional dyspnea and exercise intolerance. Although the survival 
of these patients has improved with vasodilator therapy, espe- 
cially with angiotensinconvct-ting enzyme inhibitors (l-4). the 
symptoms remain debilitating. The precise mechanisms under- 
lying the: symptoms are not known (5.6). There is little 
correlation between exerciw tolerance and resting hem@- 
namic val ;ables (7,8). Both pulmonary and peripheral facton 
(9), including skeletal myopathy (10-12) and Impaired periph- 
eral blood Bow (13), may play a role in the genesis of these 
symptoms. The proportional increase in ventilation with work 
rate, oxygen consumption and carbon dioxide output is seen in 
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&M&S. Maximal oxygen consumption was 16.6 2 0.9 versus 
29.7 * 2.2 ml/kg per min tp < O.OMM), and the ventilation-carbon 
dioxide output rrgressioo sbpe WM 37.2 i I.5 vtrsus 26.5 + I.4 
(p < O.WOl) in patients and control subjects, respec+ively. Hy- 
poxk and central hypercapak ebemosensitivity were enhanced in 
patients m.707 f 0.076 VL 0.293 f 0.056 litersMa prr % arterial 
oxygen satumtion [Sao,], p = O.OOOl and 3.15 f 0.41 vs 2.02 f 
0.25 litcrs/min per mm Hg. p = U.025, nqectively) and carrelated 
significantly dtb the vralilatwy respoase to exercise. Hypoxk 
chemosensitivity was r-ted during exercise in patients aad 
io control subjects but remained higher in the lorPer (I.!% 2 
0.27 vs. 0.685 f 0.12 litcrslmin per %SaO, p = 0.01). llw 
periplseral hyp-capnk r%mc~~sitivity of patients at rest aad 
during exercise was similar to that in cootrol snbjects, coaststeat 
with its lesser co~tributioa tn overall earboo dk&k cbemoseasi- 
tivity. 
Conrlusions. Enhanced hypoxk osd central hypercapnk de- 
mosensitivity may play a mle in mediating the iacreased ventila- 
tory response to exercise in cbronk beart failore. 
(I Am Cdl Caniid 19!b;27.W-7) 
patients with chronic heart failure during exercise as it IS in 
normal subjects (14 15). This finding suggests that the stimulus 
to exercise ventilation may be humoral and that arterial 
chemoreceptors may play ;I central role. It has been docu- 
mented previously that in normal subjects, the ventilatory 
response to cxcrcice correlates positively with chemosensitivity 
(16.17). As a corollary to this, the increased vcntilatoty re- 
sponse to exercise seer. in patients with chronic he:irt failure 
and characterized by the steeper regression slog relating 
minute ventilation to carbon dioxide output may be related to 
an increased chemosensitivity. On a more theoretic basis. it has 
also been suggested (18) that the generalized neurohormonal 
activation in chronic heart failure may not only be linked to a 
reduced input from inhibitory baroreceptors, but may also be 
caused by an increased input from excitatory chemoreceptors. 
On the basis of these considerations, we hypothesized that the 
sensitivity of chemoreceptors to afterial blood gases may he 
reset and may in part mediate the exercise hyperpnea seen in 
this condition. The purpose of this study was, therefore, to 
examine the chemosensitivity of patients with chronic heart 
failure, which hitherto has MM been evaluated, and to assess its 
relation with the vcntilatory responx to exercise. 
Methods 
Subjects. Thirty-eight patients *Gth chronic heart failure 
between 40 and 75 years of age (mean age [‘SE] ho.2 ? 1.3 
years: 35 men. 3 women) participated in the study. Patients 
with a known history of pulmo?dT and ncurologic disease 
were excluded from the study. AL patients had been in helit 
failure for >3 months. They were all treated with diuretic 
drugs, and most received angiotensinconvertinp enzyme inhib- 
itors. Nineteen patients were in New York Heart Association 
functional class II. and 16 in class III. No patient was limited by 
angina. Patient characteristics are summarized in Table I. A 
control group of 15 healthy subjects (31 10 73 years old, mean 
age 54.9 2 3.0 years; 11 men. 4 women) was also studied. 
Hypoxic and peripheral hypercapnic chernosensitivit)l. bolh 
mediated by the carotid chemoreceptors. was assessed at rest 
in all subjects. The first I5 consecutive patients with chronic 
heart failure recruited into the study also had these asses+ 
merits made during mild exercise on a cycle ergometer (Tun- 
turi) at 15 W for 10 min on two separate occasions lo evaluate 
the change in chemosensitivity on exercise. A bed exlerna’ 
work rate ~‘2% used based on the obscrvatilln that for a 
parlicular work Kite. patients with chronic heart failure have a 
higher ventillitory rc?lponsc: than normal subjects (14). In 
addilion, ccnrral hypercapnic chemosensitivity was assessed in 
IO control subjects and 3 patients to assess the role of central 
(medullarv) chcmorcccplnrs. AH rubjccls performed rdrdio- 
pulmonan: cxerciwz te$ling it) as~“i% the vcnlilaton response to 
exerciw. Subjects were told 14) avoid caffeinated products on 
the morning of the tesls. The study had been approved by Ihe 
local clllin commil~ee. and all sibjccta gave written informed 
consent. 
Transient hypoxic wntilatwy mponse ttst. Thcrc are 
three principal methods of asxcsing hypoxic chemcMnsidvi9 
using steady slate (IY). progressive (X.21) and transient (22) 
hypoxia. respectively. The absolute values obtained from each 
method arc different. hut relatively. fhey reflect the same 
indexes of chcmwn$itiviry (23.24). The transient hypoxic 
method was chosen in this study for practical ;1, 1 safety 
reasons because patienls were not subjected to 1 olonged 
episodes of hypoxia. cspeciallv during exercise. and Ine depres- 
sant effects of prolonged hypoxia on central respiratory drive 
are also avoided. 
The transient hypoxic chemosensitivity tesr was performed 
while tuhjects were qieaierl and after a period of quiel hreath- 
ing. Each subject wore a nose clip and.breathcd through a 
pneumatic respiratory valve (Innovision). which separated the 
expir-te from the inspirate. The inspilate porr wz further 
connected 10 a T-valve placed behind the subject. and, depend- 
ing on the position of the T-valve. the subject breathed either 
room air or pure nitrogen from a 4-liter reservoir bag that was 
quietly refilled from a gas cyliqder containing pure nitrogen. 
Minute ventilation was measured breath by breath using a 
heated pneumotachograph. and continuous monitoring of 
oxygen and carbon dioxide was done at the mouth by w 
spectrometry (Amis 2000, Innovision). The pneumolachom- 
eler and mass spectromeicr were calihrzted &fore each test. 
Arterial oxygen saturation was measured using a pulse oxime- 
tcr (model N-IOOE. Nelkor), set at fast mode uith a response 
time of 2 to 3 s and a lightweight ear probe clipped gently on 
the subject‘s right earlobe. After the subject breathed room air 
for several minutss. the T-valve was turned surreptitiously 
during the expiralory phase of the previous brealb so that pure 
nitrogen was inhaled for two to eight breaths. This was 
repeated IO lo I5 times to provide a wide range of arterial 
oxygen saturations from 70% to IO%. with -3min intervals 
of air breathing between eizres to dlow anerial oqp 
saturation and end-tidal carbon dioxide to return to the 
subject’s baseline. The maximal minute ventilation after each 
peti of nitrogen inhalation was obtained by aleraging the 
two largest consecutive breaths. We found t!w two-breath 
period optimal in maintaining sensitivity and r:praiwbility of 
the transient hypcrxic test as did Edelman et al. (3). The 
timal ventilation was then plotted against th: lowest arterial 
oxygen saturation reached for eveT period of nitrogen inha- 
lation. The transient hypoxic chemoscnsitivity was ohtaincd 
as the slope of the best-fit line that related ventilation IO 
arterial oxygen saturation. calculated by loa+squarch linear 
regression analysis and expressed in terms of liters per 
minute per percent oxygen saturation (litcrsimin per 
BSao,). For the transient hypoxic test during cxercisc. on 
average, only six episodes of transient hypoxia were @en in 
view of the duration of the exercise. A delay of 3 rnlhl after 
the onset of exercise was given before the hypoic chcmo- 
sensitivity testing to allow steady state (X,27). For safety 
reasons, the degree of arterial oxygen desaturation was 
deliberately kept X30%. All patients were monitored clcc- 
trocardiographically during exercise. 
Siwth carbon dioxide ventilatoy response test. 
Peripnera! hypercapnic chemosensitivity was axwssed using 
the single-breath carbon dioxide test as described by McClean 
et al, (28). The apparatus includingthe T-valve was the same as 
that described before. A smaller 2-liter reservoir hag was used. 
which was quietly refilled after each inhalation with a gas 
mixture containing 139 carbon dioxide in air. After a period of 
quiet breathing, the T-valve was turned during the expiratoq 
ph;w of the previous breath so that the subject inhaled a single 
breath of 13% carbon dioxide in air. On average, IO breaths 
were administered at -2-min intervals. As before. minute 
ventilation was measured. with continuous monitoring of car- 
bon dioxide done at the mouth. The mean minute ventilation 
of the preceding five breaths before the stimulus carbon 
dioxide breath was calculated and taken as the control venti- 
lation [v(C)]. The mean end-tidal fraction of carbon dioxide of 
these breaths was also cakulatcd and taken as the control 
end-tidal fraction of carbon dioxide [Ft~co,(C)]. The rcspmx 
ventilation after the stimulus catin dioxide hreath [v(S)1 was 
calculated by averaging the two largest conxcutive breaths 
but, unlike before, within 20 z after the stimulus breath. 
Breaths beyond this time limit were assumed to be affected by 
central chemoreceptors and therefore excluded from analysis 
(28). The end-tidal carbon dioxide concentration of the stim- 
ulus breath was considered the stimulus end-tidal fraction of 
carbon diixide [FtTcx)JS)l, The single-breath ca&m dioxide 
response was calculated using the previous variables as 
follows: 
where P, is the atmospheric pressure (mm Hg), and 47 is the 
saturated water vapor pressure (mm Hg). The mean of 10 
responses was considered the subject’s single-breath carbon 
dii response at rest and expressed in liters per minute per 
millimeter Hg (liters/min per mmHg). For the IO-min exercise 
period at 25 W on the cycle ergometer, an average of six single 
breaths of carbon dioxide were administered at shorter time 
intervals in view of increased minute ventilation and circula- 
tion during exercise. These were given 3 min after the onset of 
exerck to allow steady state. 
m dbGdc rdn~!&@ ttebn&. Central hypercap- 
nit chemasensitivity was assersed using rebreathing of carbon 
dioxide (ZY). During the tot. expired carbon dioxide is con- 
stantly returned to Ihc lungs, and as carbon dioxide accumu- 
lirtes. thih provides ti progrcs\ive carbon dioxide stimulus lo 
vrntilation. After ti period of quiet breathing, subjects re- 
breathed through a &liter hag containing a gas mixture of 7ci 
carbon diosidc in oxvgcn for 1 min; the test was stopped sooner 
tf they wcrc too hrcathlrL3 IO continue or if P~-T(I)~ exceeded 
Ill’r. II has hecn shoun (?Y) that by rehreathingof 7% carbon 
dioxide (which approximates IO venous PC o?) in oxygen. a Pco, 
equilibrium is developed rapidly in the mixed venous blood. 
arterial blood. gas in the lung and gas in the breathing bag. 
Thus. Ihe PC o2 in any one of these compartments is rcpresen- 
lativc of the other compartments. including the brain tissue. 
With thr high oxygen concentration. the peripheral hypercap- 
nit respnsc is known IO be very small or negligihle (3U.31). 
Minute ventilation was measured breath by breath. and con- 
tinuous monitoring of oxygen and carbon dioxide was done at 
the mouth by mass spectrometry. The central hypercapnic 
chemuscnsitivity was obtained irs the slope that related minute 
ventilation to PETCO~ calculated by linear regression analysis 
,md expressed in terms of liters per minute per millimeter Hg 
(literslmin prr mm Hg). We did not perform this test during 
exercise because of the uncertainties of Pco, equilibrium 
during exercise in all the compartments (nixed venous blood. 
arterial bkwd, gas in the lung and gas ill the breathing bag) 
using the same mixture of 7?i carbon dioxide in oxygen. 
Studies of reproducibility. The transient hypoxic. singlr- 
breath carbon dioxide and rehreathing carbon dioxide tests 
were repeated in seven healthy control subjects and tive 
patients with chronic heart failure lo assess reproducibility and 
the coefticient of variation. There was g& agreement he- 
!ween repeated mcasuremcnts (r = 11.93, O.hY and 0.97, 
respectively. p c: 0.0s for all three tests), with the mean 
coe@cient nf variation of the respective tests being 21.4 2 
3.w (. 21.0 2 4.Y? and 14.6 2 4.4%. accordingly, comparable 
to other studies (24,28,2Y). Similarly. the mean value of the 
respective tests in our control subjects compared favorably 
with previous data (24.25,28.2Y). 
CanGopulmma~ exercise testing, Cardiopulmonary exer- 
cise testing was performed in all subjects on a separate day IO 
determine the exercise ventilation. All exercised to exhaustion 
(respiratory exchange ratio > 1.1) using the Bruce protocol 
(32). with the addition of a “stage 0” at 1.0 mph and 5% 
gradient tor the patients with chronic heart failure. Respiratory 
gas exchange analysis was carried out by means of a respiratory 
mass spectrometer (Amis 2OtKL Innovision) using the inert gas 
dilution technique (33). The slope of the regression line 
relating minute ventilation to carbon dioxide output was used 
as an index of the vcntilatory response to exercise (IS). 
Statistieal analysis. Results are presented as mean value 2 
SE. Two-tailed Student I test was used where appropriate to 
asess the significance of results. The relation between vari- 
ables was assessed using linear regression analysis; p < 0.05 
was considered significant. 
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Figure I. Transient hypoxic chcmmensil’vi~ in pa~icols with chronic 
heart failure (CHF) versus normal suhjccls. !%a02 = aflerial onpcn 
saturation. 
Results 
Cardiopulmoaory exe&se ttsting Mean age. height and 
weight of control subjects and patients with chronic heart 
failure did not differ significantly (Table I). Also shown in 
Table I, patients with chronic heart failure had a lower 
maximal oxygen consumption (p < O.oOnI ) and higher venti- 
latory response to exercise as judged by the higher ventilation- 
carbon dioxide output regression slope compared with that fol 
control subjects (p < 0.0001). There was no significant differ- 
ence in maximal oxygen consumption (16.4 2 0.X vs. 17.3 2 
2.3 ml/kg per min). ventilation-carbon dioxide output rcgres- 
sion slope (38.13 z 1.70 vs. 34.M 5 3.40) or left ventricular 
ejection fraction (27. I 2 2.8 vs. 22.7 2 4.5%) between patients 
with chronic heart failure from ischemic heart disease and 
idiopathic dilated cardiomyopathy who participated in the 
study. 
Hypoxic cbemoscasitivity. Figure 1 shows a significanrly 
higher transient hypoxic venrilatory response in patients with 
chronic heart failure (0.707 ? 0.076 litenimin per %aol) than 
in control subjects (0.293 % 0.056 lilrrs/min per ‘iSac),). When 
the results of the transient hypoxic ventilarory test were 
analyzed separately for patierlts with chronic hearl failure from 
ischemic heart disease and idiopathic dilated cardiomyopathy. 
there was no significant difference between the two groups 
(0.642 ? 0,088 vs. 0.819 ? 0.14 literslmin per Mao,, p = 03). 
H-pie rkao6cpsitivity. Tbe peripheral hypercapnic 
chemosensitivity was higher in patients with chronic heart 
failure (0.388 2 0.04 vs. 0.310 2r 0.051 litersimin per mm Hg). 
but this did not reach statistical significance (Fig. 2). On the 
amtrary. when central hypercapnic chemosensilivity was as- 
sessed in 25 of the patients with chronic heart failure. there was 
a significant difference between patients and conboA subw 
(3.15 2 0.41 vs. 2.02 2 025 lite&nin per mm Hg. p = 0X5) 
1.2 
(Fig. 3). These 25 paiients had similar age (57.‘:! z 1.7 wan). 
maximal oxygen consumption (17.8 lr 1.1 ,ni,kg per mm). 
bcntilation-carbon dioxide output regression siop (37.8 z 
2.0) and left ventricular ejection fraction (23.4 z WTi ) whrn 
compared with the total patient group studied. Fourteen 
patients had ischemic heart disease. and nine had idiopathic 
cardiomyopathy. There W;IF no difference in central hypercap 
nit chemosensitivity between these two groups of patients 
(3.20 ? 0.51 vs. 3.27 Z 0.83 liter5’min per mm Hg. p = 0.95). 
Of thcr;e 25 patients. I I were in New York HerrI Association 
functional class II and I3 in clau III. 
Ckmosensittity, hncti4aaI impairacat and exercise veo- 
tilatwy mpoase. To see whether there wti any relation 
between hyxic and central hypercapnic chemosensitiviry and 
functional Impairment. we compared the rmpective chemosen- 
sitivity in patients in functional classes II and III. as shown in 
Figure 4. Although the hypotic chemosensitivity was higher in 
F$rrr 3. Central hypcrcapnic chrmo!&Glivity az, mravurcd by cat-bon 
dioxide (CO!) rehrrathing in paticntswilh chronic hian failure (CHF) 
WMUI normal auhjccts 
-K) ’ c - 0.015 
P = 0.41 
,---- -. 
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7$1rc A Tc,I. Relation hctwccn hypoxic chemtvjrns~~ivity and fu.w 
lional capacity showing a higher chcmwnsitiviry in NW Vorl; Iirarr 
Atiation functional class III. although not statistically significant 
because of much ovcrtapMwccn paticnis in clases II and III. llotlom 
Relation Mwccn central hypcrcapnic chrmowwitiviry and functional 
cqacity. Ahhreviatirbm a, in Figurt3 I and 1. 
functional class III than class II, this was not statistically 
significant (0.724 + 0.10~s. 0.W z 0.11 litcdmin per 5; Sao:. 
p = 0.41). In contrast, central hypercapnic chemmnsitivifv 
tended lo k more discriminatory. with patients in functional 
class I11 having a significantly higher chcmosensitivity than 
?&we 5. Relation hctwrcn ventWon-carbon dioxide OUI~UI (VE- 
VCOL?! rcgrcssion slope and tranaicnt hypoxic chcrntwnsiti~ it! do wt. 
Other ahhrcriatiom as in Figure I 
# . 
50 ”  
r.o.00 ?~O.OOl 
thosr in cl;~ss II (4.17 : tI.M, vs. 2.M ? 0.14 litets/min per mm 
ffg. p = 0.007) (also shown in Fig, 4). 
A significam corrclaGun was seen between the vent&tory 
response to exercise and hypoxic chcmosensitivity. as shown in 
Figurl. 5 (r = (1.N p = tl.001). There was 61~ a significant 
correlation between the ventilatoty response to exercise and 
central hypercapnic chemosensitivity. as shown in Figure h (r = 
O&i. p < 0.001). There was no correlation ktween the 
vcntitatory response to exercise and the peripheral hyprcap- 
nit chemusensitivity (r = O.OK. p = 0.94). 
Chemusensitivify during mild pxehse. The I5 patients 
Nith chronic heart failure who had their chemoscnsitivity 
assessed during mild exercise showed similar has&z charac- 
teristics (age 60.7 * 1.3 years: maximal oxygen consumption 
17.9 2 I.4 mlkg p’r min: ventilation-carbon dioxide output 
regression slope 34. I.1 2 2..W left ventricular ejection fraction 
27.5 t 3.6%) compared with all patients with chronic heart 
faibc as a group. As shown in Table 7. the tr,ln.Gent hypoxic 
Table 2. Summary of Chcmcncnsitivitv RLXJIIS LI Rtit and During 
Mild Excrcir in Norms1 Control Suh&\ ulld Patirnts With 
Chronic Hcan Failurr 
P~wnl\ 
Wtth (‘HF P 
(n - ltil \‘dUL 
response during exercise in these 15 patients was I.531 + 030 
litersimin per GSao: compared with O.tM 2 ft.)20 litedmin 
per SSSao, in normal subjects. Despite augmentation of the 
hypoxic chemosendtivity during exercise in both control sub- 
jects and patients with chronic heart farhue. the transrent 
hypoxic response remained significantly higher m patients. 
Also shown in Table 2. the peripheral hypcrcapnic chemoscn- 
sitivity was also augmented during cxcrcise in control subjects 
and patients. but there was no significant ?ifferenic between 
the two groups. 
When the hypoxic chemosensitivit! I’nCdwrLX! during mild 
exercise was cotrrlated with ventilation-carhjn dioxide output 
regression slope. the relation ktween these two variab!rs 
remained intact. with a correlation coelTicient of 0.41 (p = 
0.024). A weak association hctween the: Gngle-breath czrhon 
dioxide response during exercise and venttlation-carhon dioa- 
idc output regression slope was also seen (r = 0.U. p = O.DY). 
Discussion 
General findings. Little is known about chcmosensitivity in 
chronic heart failure. It has been documented th3t centrar 
hypercapnic chemoser,:,itivity is enhanced in patients with 
chronic heart failure with central sleep apnea. but hypoxic 
chcmosensitivity was not studied (34). We demonstrated in the 
present study that there is increased hvpoxs and central 
hypercapnic chemosensitivitv in patients with chronic heart 
failure. We showed that patients in functional class 111 had a 
higher chemosensitivrty than those in class II. although thiswas 
not statistically significant with respect to hypoxic chcmoscn- 
sitivity. The lack of diflerentiation may be because there is 
much overlap in hypoxic ch;mosonsitivity Ltween patrents in 
functional classes II and II: or perhaps h.Ypoxic chemosensi- 
tivity is less associated with the functional capacity of patients. 
It has to be acknowledged that even in normal subjects. both 
hypoxlc and hypercapnic chemosensitivity may va:y consider- 
ably between subjects (35). However, the central hypercapnir 
chemosensitivity was significanth higher in ,p&ients in a I ighcr 
functional class and may therefore relate more to the severi!! 
of chronic heart failure. 
The absence of a significant increase in single-breath car- 
bon dioxide response in patients with chronic heart failure ic 
surprismg although no; totally unexpected. The single-breath 
carbon dioxide responx test measures the pcr;pheral hypcr- 
capnic chemosensitivity. Functional hypercapnic chemosens; 
tivity is predominantly mediated by the central citemurczep 
ton. Some studies (.W) have shown that the peripheral 
hypercapnic chemt~nsitivity recounts for ortry chwt one 
tenth of overall carbon dioxide chen~naitivity. 
hlechmisrns causing bcrtwud elnmomsitii. There 
arc several possible mechanisms causing increased hypoxic 
chemosensitivity in patients with chronic heart failure. It is 
recognized that there are neurohormonaf changes (.%.37) in 
patients with chronic heart failure. and these include increased 
catecholamine Icvek. Catecholamines are known lo potentiale 
che~nsitivity (38.39). Peripheral bland flow is also known 
lo hc rcduccd in chronic hrart failure (13). and this may be 
related to redaced cardiac:~utput or tncreawd vasomotor tone. 
it has been prcvious!y +uggcsted that a decrcasc ill chemorc- 
ceptor Mood How. causing an ;schemic hvxoxia. may alw 
mcdiat.: an increay: in chemotinGvity (40). 
Mechanisms causing altered central hyxercapnic chcmtnen- 
sitivitv arc ;F3rc obscure. Alteration in central nrurogenic 
input or si;nab from muscl: erpcrccepton (41.42) may induce 
ch;tlgC\ in central hypercapnic cnenloscnsitivrty. Mtcmativcly. 
signals from muscle ergoreceptors may feed directly into the 
re\piratoF control centers. causmg ceMral augmsntJtion of 
both medu’tary and carotid chemoreceptor input. We have 
recently shoun that !he contribution of ergorcceptors to the 
vcntilato? rcsponsc to cxercix IS higher in patients with 
chronic heart failure than in control subjects (43). Early lactic 
acidosis during exerciw may reduce the buffering ability ir. 
patients with chrouic heart failure aith consequent inr:e;ud 
cScmorcceptor acti+ but this cannot explain the increased 
chemocensitivity at rest. Perhaps the interaction of carbon 
dioxide with other ventitatory control mechanisms may offer 
clue.. It may b: that the respiratory control centers are 
similarly and nluthpcifically more responsive to vdrioiis stimuli 
includinu carbon dioxide and exercise (4). 
ReMioll llellmn cbcmoscnsittiIy ad excmise wltilhoa. 
The role of chemcrsen~itivity in mediating the ventilalory 
rcsponw: to cxrrcice is not known in chronic heart failure. !n 
normJ sutjrcts. it has been shown in one study that carbon 
dioxide &mtKcnsitivity. a? measllrcd by the rebrcathing 
method, is related to the ventilato5 response to exercise (In). 
In another study. exercise ventilation has been shown to be 
pos*‘ivrly corr&a~ed with both hyprxic and hyvrcapnic che- 
mosensitivity in healthy subjects (17). The mechanisms @ 
which chsmorzceptors may mediate exercise hyperpnra re- 
main unckar. becz~use there is litttc Ytituation in arterial 
Mood gscs. the puurtive stimuli. dui,ng exercise. Suggested 
rtechanisms include an increased gain in chermrsensilivity 
during cxrrcisc (4S.a). Augment,.ion in chcmosemitivity 
during exercise has been well documented in normal subjects 
(38.47). In other words. for a given partial pressure: of arterial 
blood gases. it represenls a higher stimdus to ventitalion than 
otherwise, had the chemosensrtivity not ken enhanced. Thus. 
the absence of significant hypoxemia or hypercapnia does n01 
exclude the existence of increard chemoxnrilivity. In uur 
study, we showed an increase in rest hypoxic and cenlral 
hyprcapnic chcmosensitivity in patients with chronic heart 
failure crbmpared with that in nrrmal subjects. There WAS ab, 
a significant degree of correlation between resting chemosefl- 
ritivity and rhe rentilatory responu IO exercise. Hypxxic and 
hvprcapnic (at least the peripheral component) chemosensi- 
ti& were shown IO be augmented in p&ems with chronic 
heart failure during excrcisc. * augmentation in chemosen- 
sitivity during exe&c may be explained by a further increase 
in catccholamiocs during cxercisc i-38). ekzatron of arterial 
potGum level (48) or perhaps early lactic acidosis duriog 
exgd. Increased odations in dtierial carbon dtidc. 
own and pH caused b exerck and exaggerated in hcuC 
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failure may also be a possible mechanism of augmentation of meosuremrnt of atierial blood samples (56.57). Furthermore, 
chernosensitivity during exercise. The potenti importance of as shown by Shaw et al. (24). the transient method can give as 
such oscillations as a mechanism by which chemoreceptors good an index of hypoxic chemosensitivity as the progressive 
method. may a&t exercise hyperpnea has been documented previously 
(4950). In chronic heart failure, the increased ventilatory 
response to exercise is often attributed to the increase in dead 
space ventilation (51). However, it remains 10 k answered 
how this dead space is sensed by the body, particularly if 
arterial blood gases remam little changed in chronic heart 
failure (52). Increased physiologic dead space and ventilation- 
perfusion mismatch may well increase the amplitude of oscil- 
lations in blood gases that is sensed by chemoreceptors. They 
may therefore also by important in mediating the effects of 
increased dead space and ventilation-perfuaior. mismatch in 
chronic heart failure. 
Coeelns~ The increase in chemosensitivity may serve as 
a compensatory mechanicm producing an increase in ventila- 
tory response during exercise and thereby preserving blood g* 
homecntasis. including maintaining arterial oxygen concentra- 
tion. In fact. it has been shown (53) that increasing inspired 
oxygen concentration during exercise improves breathlessness 
and reduces minute ventilation in these patients. Other inves- 
tigators (54) have reported mechanisms such as increased 
erylhropoiesis that directly improve arterial oxygen content In 
chronic heart failure patients to compensate for reducrd 
systemic arterial oxygen deliver). 
In conclusion. there is increased hypoxic and central hyper- 
capnic chemosensitivity in patients with chronic heart failure. 
Both hypoxic and hypercapnic chemosensitivity appear to 
correlate well with the ventilatory response to exercise. Al- 
though this association does not necessarily mean causation, 
arterial chemoreceptors may mediate the exercise hyperppea 
seen in patients with this condition. The control of ventilation 
during exercise is complex, probably more so in chronic heart 
failure. Therefore, although increased chemosensitivily may 
play a role in the exercise hyperpnea in chronic heart failure, 
there are likely IO be other factors involved. Furthermore, 
although this study shows the association between enhanced 
chemosensitivity and the increased ventilatory response to 
exercise, it should be emphaswd that the latter is not synon- 
ymous with the sensation of dyspnea. It thus remains to be seen 
whether drugs that suppress chemosensitivity, such as mild 
opiates (55). would be of therapeutic benefit in retieving the 
debilitating symptoms of breathlessness in chronic heart fail- 
ure. 
Umit&b~ oftbe at&y. With the transient hypoxic chc- 
mc6ensitivity test, both the arterial oxygen desaturation and 
the resultant ventilatory response are fleeting in nature. The 
measurement of arterial oxygen saturation and the use of a 
Wreath period to define maximal minute ventilation in such 
eatditions. although IWEWIYY under the constraints of the 
method. may give rise to errors. However. a pulse oximeter 
(Mkor NGOOE) with a fast response time of 2 to 3 s was used 
in W Study. Previous Studies have demonstraIed the accuracy 
(23%) and reliability Of arterial oxygen saturation obtained by 
puk oximeter of this partidar mu&l in comparison to direct 
From the results of the first 15 consecutive patients with 
chronic heart failu e. we found that the hypoxic chemosensi- 
tivity was significantly higher in chronic heart failure, kth at 
rest and during exercise. We therefore discontinued assessing 
the exercise chemosensitivity of the remaining patients. pri- 
marily kcause hypoxia during exercise was unpleasant to 
patients and had a certain associated risk. These 15 patients 
had similar age. exercise capacity, tadionuclide ejection frac- 
tion and resting chcmosensitivity compared with all the pa- 
tients with chronic heart failure we studied as a whole. Despite 
only a randomI}- chten subgroup of subjects having had the 
carbon dioxide rebreathing test. we were able to demonstrate 
that the central hypercapnic chemoscnnsitivity was increased in 
patients with chronic heart failure. be did not attempt to 
measure central hypercapnic chemosnsitivity during exercise., 
for the reawns stated, which may have otherwise added more 
information lo our St+. 
Finally. because of the obvious lin+ation of using ventila- 
tory changes to quantitatc chemosensir;vity. it is not possible to 
distinguish whether the increased ventilatory responses to 
hypoxia or hypercapma are solety retated to an increased gain 
in intrinsic chemoreccptor tunction or whether they reflect the 
sitered kinetics caused by an increased dead space in heart 
failure. Howcber. 3% discussed earlier. there are several abnor- 
malities in chronic heart failure that may cause an increased 
chemosensitivity. thus making it unlikely that the results in this 
study arc largely caused by an increased dead spuce. Further- 
more, there is a fundamental difference between the ventila- 
tory response to metabolic changes during exercise and the 
vc,ltilatory response to hypo!.ia or hypercapnia. as in the tests 
of chemosensitivity, in relation to dead space. The ventilatory 
rqonse lo exercise represents a response to an endogenous 
load, whereas rhe latter represents that to an external stimulus. 
An increased dead space may actually diminish the level of the 
external stimulation reaching the arterial chemoreceptors. 
That there was an increase in chemosensitivity thcrcfore 
suggests that there is an inherent change in chemoreceptor 
function. 
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